{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T01:22:22Z","timestamp":1790472142411,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s00417-021-05477-6","type":"journal-article","created":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T08:02:51Z","timestamp":1635753771000},"page":"41-45","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Restoring vision using optogenetics without being blind to the risks"],"prefix":"10.1007","volume":"260","author":[{"given":"Alexander R.","family":"Harris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,1]]},"reference":[{"key":"5477_CR1","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/465026a","volume":"465","author":"L Buchen","year":"2010","unstructured":"Buchen L (2010) Neuroscience: illuminating the brain. Nature 465:26\u201328. https:\/\/doi.org\/10.1038\/465026a","journal-title":"Nature"},{"key":"5477_CR2","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1080\/21507740.2014.911216","volume":"5","author":"H Maslen","year":"2014","unstructured":"Maslen H, Savulescu J (2014) First phase 1 optogenetic trials should be conducted in people who are dying. AJOB Neurosci 5:16\u201318. https:\/\/doi.org\/10.1080\/21507740.2014.911216","journal-title":"AJOB Neurosci"},{"key":"5477_CR3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1080\/21507740.2014.911213","volume":"5","author":"F Gilbert","year":"2014","unstructured":"Gilbert F, Harris AR, Kapsa RMI (2014) Controlling brain cells with light: ethical considerations for optogenetic clinical trials. AJOB Neurosci 5:3\u201311. https:\/\/doi.org\/10.1080\/21507740.2014.911213","journal-title":"AJOB Neurosci"},{"key":"5477_CR4","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s11569-020-00377-1","volume":"14","author":"AK Adamczyk","year":"2020","unstructured":"Adamczyk AK, Zawadzki P (2020) The memory-modifying potential of optogenetics and the need for neuroethics. NanoEthics 14:207\u2013225. https:\/\/doi.org\/10.1007\/s11569-020-00377-1","journal-title":"NanoEthics"},{"key":"5477_CR5","doi-asserted-by":"publisher","unstructured":"Zawadzki P, Adamczyk AK (2021) Personality and authenticity in light of the memory-modifying potential of optogenetics. Am J Bioeth - Neurosci. https:\/\/doi.org\/10.1080\/21507740.2020.1866097","DOI":"10.1080\/21507740.2020.1866097"},{"key":"5477_CR6","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12910-020-00532-z","volume":"21","author":"SZK Tan","year":"2020","unstructured":"Tan SZK, Lim LW (2020) A practical approach to the ethical use of memory modulating technologies. BMC Med Ethics 21:89. https:\/\/doi.org\/10.1186\/s12910-020-00532-z","journal-title":"BMC Med Ethics"},{"key":"5477_CR7","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1080\/21507740.2020.1866104","volume":"12","author":"F Gilbert","year":"2021","unstructured":"Gilbert F, Harris AR, Kidd M (2021) Burnt in your memory or burnt memory? Ethical issues with optogenetics for memory modification. AJOB Neurosci 12:22\u201324. https:\/\/doi.org\/10.1080\/21507740.2020.1866104","journal-title":"AJOB Neurosci"},{"key":"5477_CR8","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1080\/21507740.2013.863252","volume":"5","author":"F Gilbert","year":"2014","unstructured":"Gilbert F, Goddard E (2014) Thinking ahead too much: speculative ethics and implantable brain devices. AJOB Neurosci 5:49\u201351. https:\/\/doi.org\/10.1080\/21507740.2013.863252","journal-title":"AJOB Neurosci"},{"key":"5477_CR9","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1080\/21507740.2014.911780","volume":"5","author":"S M\u00fcller","year":"2014","unstructured":"M\u00fcller S, Walter H (2014) Neither speculative nor narrow-minded ethics is needed for optogenetics-based DBS in psychiatry and neurology. AJOB Neurosci 5:12\u201314. https:\/\/doi.org\/10.1080\/21507740.2014.911780","journal-title":"AJOB Neurosci"},{"key":"5477_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01351-4","author":"J-A Sahel","year":"2021","unstructured":"Sahel J-A, Boulanger-Scemama E, Pagot C et al (2021) Partial recovery of visual function in a blind patient after optogenetic therapy. Nat Med. https:\/\/doi.org\/10.1038\/s41591-021-01351-4","journal-title":"Nat Med"},{"key":"5477_CR11","unstructured":"Nih (2014) Informed consent guidance for human gene transfer trials subject to the NIH guidelines for research involving recombinant or synthetic nucleic acid molecules. https:\/\/osp.od.nih.gov\/wp-content\/uploads\/2014\/10\/IC2013.pdf. Accessed 12 Oct 2021"},{"key":"5477_CR12","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1080\/23294515.2020.1818876","volume":"11","author":"S Desine","year":"2020","unstructured":"Desine S, Hollister BM, Abdallah KE et al (2020) The meaning of informed consent: genome editing clinical trials for sickle cell disease. AJOB Empir Bioeth 11:195\u2013207. https:\/\/doi.org\/10.1080\/23294515.2020.1818876","journal-title":"AJOB Empir Bioeth"},{"key":"5477_CR13","doi-asserted-by":"publisher","unstructured":"Gilbert F, Pham C, Viana JNM, Gillam W (2019) Increasing brain-computer interfaces media depictions: pressing ethical concerns. Brain-Computer Interfaces. 6(3):49\u201370. https:\/\/doi.org\/10.1080\/2326263X.2019.1655837","DOI":"10.1080\/2326263X.2019.1655837"},{"key":"5477_CR14","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1080\/14712598.2020.1740676","volume":"20","author":"TA Ciulla","year":"2020","unstructured":"Ciulla TA, Hussain RM, Berrocal AM, Nagiel A (2020) Voretigene neparvovec-rzyl for treatment of RPE65-mediated inherited retinal diseases: a model for ocular gene therapy development. Expert Opin Biol Ther 20:565\u2013578. https:\/\/doi.org\/10.1080\/14712598.2020.1740676","journal-title":"Expert Opin Biol Ther"},{"key":"5477_CR15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2104840","author":"A Greinacher","year":"2021","unstructured":"Greinacher A, Thiele T, Warkentin TE et al (2021) Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination. N Engl J Med. https:\/\/doi.org\/10.1056\/NEJMoa2104840","journal-title":"N Engl J Med"},{"key":"5477_CR16","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1084\/jem.20081786","volume":"205","author":"M Perreau","year":"2008","unstructured":"Perreau M, Pantaleo G, Kremer EJ (2008) Activation of a dendritic cell-T cell axis by Ad5 immune complexes creates an improved environment for replication of HIV in T cells. J Exp Med 205:2717\u20132725. https:\/\/doi.org\/10.1084\/jem.20081786","journal-title":"J Exp Med"},{"key":"5477_CR17","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1080\/21507740.2012.666323","volume":"3","author":"F Gilbert","year":"2012","unstructured":"Gilbert F, Harris AR, Kapsa RMI (2012) Efficacy testing as a primary purpose of phase 1 clinical trials: is it applicable to first-in-human bionics and optogenetics trials? AJOB Neurosci 3:20\u201322. https:\/\/doi.org\/10.1080\/21507740.2012.666323","journal-title":"AJOB Neurosci"},{"key":"5477_CR18","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1080\/23294515.2019.1592264","volume":"10","author":"J Lawton","year":"2019","unstructured":"Lawton J, Blackburn M, Rankin D et al (2019) Broadening the debate about post-trial access to medical interventions: a qualitative study of participant experiences at the end of a trial investigating a medical device to support type 1 diabetes self-management. AJOB Empir Bioeth 10:100\u2013112. https:\/\/doi.org\/10.1080\/23294515.2019.1592264","journal-title":"AJOB Empir Bioeth"},{"key":"5477_CR19","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/s41583-018-0004-5","volume":"19","author":"G L\u00e1zaro-Mu\u00f1oz","year":"2018","unstructured":"L\u00e1zaro-Mu\u00f1oz G, Yoshor D, Beauchamp MS et al (2018) Continued access to investigational brain implants. Nat Rev Neurosci 19:317\u2013318. https:\/\/doi.org\/10.1038\/s41583-018-0004-5","journal-title":"Nat Rev Neurosci"},{"key":"5477_CR20","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s12152-014-9224-1","volume":"8","author":"F Gilbert","year":"2015","unstructured":"Gilbert F (2015) Self-estrangement & deep brain stimulation: ethical issues related to forced explantation. Neuroethics 8:107\u2013114. https:\/\/doi.org\/10.1007\/s12152-014-9224-1","journal-title":"Neuroethics"},{"key":"5477_CR21","doi-asserted-by":"publisher","unstructured":"Lau B, Meier N, Serra G, et al (2019) Axial symptoms predict mortality in patients with Parkinson disease and subthalamic stimulation. Neurology 92:e2559 LP-e2570. https:\/\/doi.org\/10.1212\/WNL.0000000000007562","DOI":"10.1212\/WNL.0000000000007562"},{"key":"5477_CR22","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1136\/jnnp-2012-304715","volume":"85","author":"D Ngoga","year":"2014","unstructured":"Ngoga D, Mitchell R, Kausar J et al (2014) Deep brain stimulation improves survival in severe Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 85:17\u201322. https:\/\/doi.org\/10.1136\/jnnp-2012-304715","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"5477_CR23","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/ene.12614","volume":"23","author":"M Bang Henriksen","year":"2016","unstructured":"Bang Henriksen M, Johnsen EL, Sunde N et al (2016) Surviving 10 years with deep brain stimulation for Parkinson\u2019s disease \u2013 a follow-up of 79 patients. Eur J Neurol 23:53\u201361. https:\/\/doi.org\/10.1111\/ene.12614","journal-title":"Eur J Neurol"},{"key":"5477_CR24","doi-asserted-by":"publisher","unstructured":"Gilbert F, Lancelot M (2021) Incoming ethical issues for deep brain stimulation: when long-term treatment leads to a \u2018new form of the disease.\u2019 J Med Ethics 47:20 LP \u2013 25. https:\/\/doi.org\/10.1136\/medethics-2019-106052","DOI":"10.1136\/medethics-2019-106052"},{"key":"5477_CR25","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1089\/jpm.2019.0129","volume":"23","author":"LR Sankary","year":"2019","unstructured":"Sankary LR, Ford PJ, Machado AG et al (2019) Deep brain stimulation at end of life: clinical and ethical considerations. J Palliat Med 23:582\u2013585. https:\/\/doi.org\/10.1089\/jpm.2019.0129","journal-title":"J Palliat Med"},{"key":"5477_CR26","doi-asserted-by":"publisher","first-page":"20","DOI":"10.2307\/3562038","volume":"17","author":"PS Appelbaum","year":"1987","unstructured":"Appelbaum PS, Roth LH, Lidz CW et al (1987) False hopes and best data: consent to research and the therapeutic misconception. Hastings Cent Rep 17:20\u201324. https:\/\/doi.org\/10.2307\/3562038","journal-title":"Hastings Cent Rep"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-021-05477-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-021-05477-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-021-05477-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T10:31:51Z","timestamp":1744194711000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-021-05477-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,1]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["5477"],"URL":"https:\/\/doi.org\/10.1007\/s00417-021-05477-6","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,1]]},"assertion":[{"value":"10 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}